Prognostic value of fasting hyperglycemia in patients with COVID-19 – Diagnostic test accuracy meta-analysis

This meta-analysis aimed to assess the prognostic value of fasting hyperglycemia in patients with COVID-19. A systematic literature search on PubMed, Embase, and Scopus were performed up until February 18, 2021. Fasting hyperglycemia was defined as fasting plasma glucose level above the reference va...

Full description

Saved in:
Bibliographic Details
Published in:Obesity medicine 2021-05, Vol.23, p.100333-100333, Article 100333
Main Authors: Handayani, Dewi Ratih, Juliastuti, Henny, Nawangsih, Eka Noneng, Kusmala, Yudith Yunia, Rakhmat, Iis Inayati, Wibowo, Arief, Pranata, Raymond
Format: Article
Language:English
Subjects:
Coronavirus
Glucose
Mortality
SARS-CoV-2
Severity
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This meta-analysis aimed to assess the prognostic value of fasting hyperglycemia in patients with COVID-19. A systematic literature search on PubMed, Embase, and Scopus were performed up until February 18, 2021. Fasting hyperglycemia was defined as fasting plasma glucose level above the reference value. The outcome of interest was poor outcome, which was a composite of mortality and severe COVID-19. The effect estimate was in odds ratio (OR). There were 9045 patients from 12 studies included in this systematic review and meta-analysis. The prevalence of fasting hyperglycemia was 29%. The incidence of poor outcome was 15%. Fasting hyperglycemia was associated with poor outcome in COVID-19 (OR 4.72 [3.32, 6.72], p 
ISSN:2451-8476
2451-8476
DOI:10.1016/j.obmed.2021.100333